Filters
Other countries
Results: 1 to 20 of 20
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Premature Ovarian Failure (POF) Panel PreventionGenetics, part of Exact Sciences United States | 19 | 21 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
PreventionGenetics, part of Exact Sciences United States | 96 | 105 |
|
Premature ovarian failure (WES based NGS panel of 47 genes, including analysis of CNVs) CGC Genetics Unilabs Portugal | 1 | 47 |
|
CGC Genetics Unilabs Portugal | 1 | 129 |
|
Panel of premature ovarian failure. NGS panel of 15 genes. Genologica Medica Spain | 50 | 15 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Genetic Services Laboratory University of Chicago United States | 10 | 93 |
|
Premature Ovarian Failure Panel GeneDx United States | 6 | 22 |
|
Premature ovarian failure: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 17 | 15 |
|
Fulgent Genetics United States | 92 | 56 |
|
Fulgent Genetics United States | 76 | 41 |
|
Premature Ovarian Failure: Sequencing Panel and FMR1 CGG Repeat Analysis CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 21 |
|
Premature Ovarian Failure (POF) and Related Disorders , Panel Massive Sequencing (NGS) 14 Genes Reference Laboratory Genetics Spain | 14 | 14 |
|
Phosphorus Female Infertility Panel Phosphorus Diagnostics LLC United States | 9 | 26 |
|
Premature Ovarian Failure Panel Blueprint Genetics Finland | 1 | 15 |
|
Premature Ovarian Failure Panel Genetic Services Laboratory University of Chicago United States | 10 | 26 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.